S. Parikh

发表

Reduction in Mortality after Umbilical Cord Blood Transplantation in Children Over a 20-Year Period (1995-2014).

J. Kurtzberg, A. Sung, M. Kelly, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with acute leukemia.

J. Kurtzberg, J. Cornish, C. Peters, 2010, Pediatric clinics of North America.

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.

S. Mustjoki, H. Dombret, M. Höglund, 2008, Blood.

Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.

M. Poe, J. Provenzale, J. Kurtzberg, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic stem cell transplantation with omidubicel in sickle cell disease.

J. Kurtzberg, J. Brochstein, S. Parikh, 2021, Blood advances.

HSCT in Benign Hematological Disorders

S. Chandrakasan, S. Parikh, 2020, Contemporary Bone Marrow Transplantation.

A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.

M. Ayas, A. Thompson, M. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

E. Neufeld, F. Trachtenberg, A. Thompson, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome

S. Prahalad, E. Waller, C. Bennett, 2021, Blood.

central nervous system Philadelphia chromosomepositive leukemia Dasatinib crosses the blood-brain barrier and is an efficient therapy for

S. Mustjoki, H. Dombret, M. Höglund, 2009 .

S. Spellman, J. Panepinto, B. Logan, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning (RIC) in children with nonmalignant disorders (NMD) undergoing unrelated donor umbilical cord blood transplantation (UCBT).

P. Szabolcs, S. Parikh, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Results of Cord Blood Transplantation in Children with Nonmalignant Hematologic Conditions

J. Kurtzberg, K. Page, S. Parikh, 2014 .

Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.

J. Kurtzberg, H. Malech, V. Prasad, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Excellent Outcomes Following Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome: A PIDTC Report.

L. Notarangelo, H. Ochs, J. Puck, 2020, Blood.

Outcome of hematopoietic cell transplantation for DNA double‐strand break repair disorders

A. Fischer, A. Schulz, B. Wolska-Kuśnierz, 2018, The Journal of allergy and clinical immunology.

Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.

J. Troy, J. Kurtzberg, V. Prasad, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Kurtzberg, V. Prasad, P. Szabolcs, 2008, Blood.

Correction of chronic granulomatous disease after second unrelated‐donor umbilical cord blood transplantation

J. Kurtzberg, V. Prasad, P. Szabolcs, 2007, Pediatric blood & cancer.

A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.

J. Kurtzberg, D. Niedzwiecki, K. Komanduri, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy

L. Notarangelo, J. Puck, T. Torgerson, 2022, Journal of Clinical Immunology.

Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.

J. Kurtzberg, M. Cavazzana‐Calvo, E. Gluckman, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-Term Functional Outcomes after Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease.

J. Troy, J. Kurtzberg, V. Prasad, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience

N. Chao, R. Buckley, P. Szabolcs, 2015, Pediatric blood & cancer.

Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

L. Notarangelo, J. Puck, K. Sullivan, 2017, Blood.

Congenital hemophagocytic lymphohistiocytosis presenting as thrombocytopenia in a newborn.

C. Thornburg, Ashley Hinson, N. Prose, 2015, Journal of pediatric hematology/oncology.

Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy

Jiqiang Yao, D. Kohn, J. Sleasman, 2021, Journal of Clinical Immunology.

Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant

M. Pasquini, B. George, R. Gale, 2019, JAMA pediatrics.

Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation

J. Kurtzberg, K. Mahadeo, V. Prasad, 2015, Pediatric transplantation.

Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.

J. Kurtzberg, G. Sempowski, V. Prasad, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ethical considerations of using a single minor donor for three bone marrow harvests for three HLA‐matched siblings with primary immunodeficiency

J. Kurtzberg, R. Pentz, V. Prasad, 2019, Pediatric blood & cancer.

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey

L. Notarangelo, J. Walter, J. Puck, 2020, Frontiers in Immunology.

Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study

Rebekah K. Loving, D. Neuberg, Catherine J. Wu, 2019, American journal of hematology.

Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)

E. Neufeld, F. Trachtenberg, A. Thompson, 2013 .

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

G D Long, K. Sullivan, J. Kurtzberg, 2013, Bone Marrow Transplantation.

Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.

M. Qayed, A. Haight, K. Williams, 2022, Blood advances.

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT

L. Notarangelo, J. Puck, T. Torgerson, 2019, Journal of Clinical Immunology.

Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency

L. Notarangelo, J. Walter, L. Henderson, 2020, Frontiers in Immunology.

Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.

L. Notarangelo, J. Walter, R. Geha, 2019, The journal of allergy and clinical immunology. In practice.

Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art

J. Talano, R. Marsh, J. Connelly, 2018, Journal of the Pediatric Infectious Diseases Society.

J. Kurtzberg, V. Prasad, P. Szabolcs, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Use of Letermovir for Salvage Therapy for Resistant Cytomegalovirus in a Pediatric Hematopoietic Stem Cell Transplant Recipient.

D. Lugo, Matthew G. Varga, V. Prasad, 2019, Journal of the Pediatric Infectious Diseases Society.

Clear cell sarcoma of the kidney: an unusual presentation and review of the literature.

M. Chintagumpala, M. Hicks, S. Blaney, 1998, Journal of pediatric hematology/oncology.

cDNA sequencing increases the molecular diagnostic yield in Chediak-Higashi syndrome

W. Gahl, M. Gunay‐Aygun, J. Stephen, 2023, Frontiers in Genetics.

Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation

K. Leung, E. Horwitz, M. Qayed, 2022, Blood advances.

Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency.

J. Ziegler, A. Schulz, R. Geha, 2019, The journal of allergy and clinical immunology. In practice.

Resolution of CGD Related Colitis after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Granulomatous Disease—Early Results From the 6903 Study of the Primary Immune Deficiency Treatment Consortium (PIDTC)

L. Notarangelo, J. Puck, K. Sullivan, 2018 .

Umbilical Cord Blood Transplantation for Cartilage Hair Hypoplasia: A Single Center Experience Demonstrates Excellent Outcomes Using Myeloablative Preparative Regimens

J. Kurtzberg, V. Prasad, T. Driscoll, 2016 .

Treatment of pediatric patients with Sanfilippo syndrome (MPS IIIA and IIIB) with unrelated umbilical cord blood transplantation

J. Kurtzberg, V. Prasad, P. Szabolcs, 2005 .

Outcomes of Second Transplants for Patients with Hematological Malignancies Who Relapse after First Transplant: A Retrospective Analysis of a Single Institution Experience

J. Troy, J. Kurtzberg, V. Prasad, 2017 .

Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.

J. Kurtzberg, O. Frankfurt, D. Cilloni, 2023, Transplantation and cellular therapy.

Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901

L. Notarangelo, J. Puck, K. Sullivan, 2015 .

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium

L. Notarangelo, J. Puck, T. Torgerson, 2023, The Lancet.

Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies.

Michael J. Eckrich, N. Kapoor, C. Dvorak, 2018, The Journal of allergy and clinical immunology.

Long-Term Functional Outcomes following Hematopoietic Stem Cell Transplantation for Krabbe Disease

J. Troy, J. Kurtzberg, V. Prasad, 2016 .

HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh

J. Walter, Sujal Ghosh, R. Buckley, 2022, Blood advances.

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Elias T. Zambidis, S. Pai, P. Hanley, 2024, Nature communications.

Diagnosis of 22q11.2 Deletion Syndrome and Artemis Deficiency in Two Children with T-B-NK+ Immunodeficiency

D. McDonald-McGinn, D. Moshous, M. Markert, 2012, Journal of Clinical Immunology.

Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.

C. Deming, S. Conlan, J. Segre, 2023, The Journal of allergy and clinical immunology.

Risk Factor Analysis of Outcomes after Unrelated Cord Blood Transplantation for Children with Hurler’s Syndrome. An Eurocord-Duke University Collaborative Study.

J. Kurtzberg, M. Cavazzana‐Calvo, E. Gluckman, 2007 .

A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.

M. Ayas, A. Thompson, M. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.

L. Notarangelo, J. Walter, R. Geha, 2019, The journal of allergy and clinical immunology. In practice.

Genotype, Oxidase Status, and Preceding Infection or Autoinflammation Do Not Affect Allogeneic HCT Outcomes for CGD.

L. Notarangelo, J. Puck, T. Torgerson, 2023, Blood.

58: Risk Factor Analysis of Outcomes After Unrelated Cord Blood Transplantation for Children with Hurlers Syndrome. An EUROCORD-Duke University Collaborative Study

J. Kurtzberg, M. Cavazzana‐Calvo, E. Gluckman, 2008 .

Transplant Outcomes and Stabilization of Neurological Function in Young Children with MPS III (Sanfilippo Syndrome) after Unrelated Donor Umbilical Cord Blood Transplantation.

J. Kurtzberg, V. Prasad, P. Szabolcs, 2005 .